Dr. Ronald Marc Sharrin, PHD Psychologist - Adult Development & Aging Medicare: Not Enrolled in Medicare Practice Location: 20774 Hillside Dr, Topanga, CA 90290 Phone: 310-455-1200 |
Christine A Brown, AMFT Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1145 Old Topanga Canyon Rd, Topanga, CA 90290 Phone: 310-467-5571 |
Dr. Dominique Bressi, PSY.D. Psychologist - Clinical Medicare: May Accept Medicare Assignments Practice Location: 2039 Tuna Canyon Rd, Topanga, CA 90290 Phone: 310-455-1782 Fax: 310-455-1672 |
Ms. Yolande Michaels, PHD Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 1757 Arteique Road, Topanga, CA 90290 Phone: 310-455-7073 Fax: 310-455-7073 |
Dr. Lisa Sloan, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 164 Muerdago Rd, Topanga, CA 90290 Phone: 310-455-1618 |
John Pietrzak, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 21838 Encina Rd, Topanga, CA 90290 Phone: 310-663-7163 |
Mr. Larry Shaw, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2215 N Topanga Canyon Blvd, Topanga, CA 90290 Phone: 323-351-1185 |
News Archive
A team of US-based researchers recently conducted an illuminating study that explores this method and its potential uses. In doing so, they have underscored the potential utility of wastewater surveillance in managing SARS-CoV-2 outbreaks.
People collect things all the time: books, newspapers, stamps. But when a casual hobby turns into an incessant need to hoard, it becomes a disorder that requires intervention. But how much of hoarders' behaviours are influenced by their loved ones? Ryerson researchers are investigating these relationships in a new study looking at the link between family members' behaviours and individuals who hoard.
People who possess a greater understanding of finance are less likely to fret about life in their twilight years.
Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy agent had longer survival than patients treated with the standard targeted drug, said an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.
› Verified 2 days ago